Iridex ophthalmic laser system for glaucoma treatment receives FDA approval

Iridex (NASDAQ:IRIX; Mountain View, CA) has received FDA clearance to market its Cyclo G6 laser system designed solely for use in treating glaucoma and its symptoms. The system is dedicated specifically to treat patients diagnosed with a range of glaucoma disease states, and features the company's proprietary MicroPulse tissue-sparing technology and a family of single-use probes that connect to a laser console.

Related: Iridex laser delivery system cleared for noninvasive treatment of retinal diseases

"MicroPulse allows for a clinically effective and repeatable option that can slow the progression of the disease and delay both surgical intervention and ultimate blindness," states glaucoma and cataract specialist Robert Noecker, MD, of the Ophthalmic Consultants of Connecticut (Fairfield, CT).

The Cyclo G6 Laser System will initially be sold with two disposable delivery probes, the MicroPulse P3 probe and the G-Probe, and the company plans a series of additional new probe introductions in the coming year that allow for a broader range of application in glaucoma treatment.

-----

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World